SOS1 regulates HCC cell epithelial-mesenchymal transition via the PI3K/AKT/mTOR pathway

Yonghe Li1, Yaolin Yin1, Yi He1

  • 1Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepato-Biliary-Pancreatic-Intestinal Disease, North Sichuan Medical College, Nanchong, China.

Insights

Son of sevenless homolog 1 (SOS1) promotes hepatocellular carcinoma (HCC) invasion and metastasis by activating the PI3K/AKT/mTOR pathway and epithelial-mesenchymal transition (EMT). Targeting SOS1 may offer a new therapeutic strategy for liver cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hepatocellular carcinoma (HCC) is a major global health concern with limited effective treatments.
  • Understanding the molecular mechanisms driving HCC invasion and metastasis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of son of sevenless homolog 1 (SOS1) in the invasion and metastasis of hepatocellular carcinoma (HCC) cells.
  • To explore the underlying molecular pathways, including epithelial-mesenchymal transition (EMT) and the PI3K/AKT/mTOR pathway, influenced by SOS1.

Main Methods:

  • SOS1 knockdown and overexpression were achieved in HCC cell lines (HepG2, Huh7) using siRNA and lentivirus.
  • Quantitative PCR (q-PCR) and Western blotting (WB) were used to analyze gene and protein expression levels.
  • Transwell assays assessed cell invasion and migration in vitro, and a lung metastasis model evaluated in vivo metastatic potential.

Main Results:

  • High SOS1 expression correlated with worse prognosis in human HCC.
  • SOS1 knockout significantly reduced HCC cell invasion, migration, and lung metastasis in mice.
  • SOS1 inhibition suppressed EMT and the PI3K/AKT/mTOR pathway in HCC cells, while SOS1 overexpression had opposite effects.

Conclusions:

  • SOS1 promotes HCC invasion, migration, and metastasis, potentially by inducing EMT via activation of the PI3K/AKT/mTOR pathway.
  • SOS1 represents a promising therapeutic target for hepatocellular carcinoma.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K